These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10663962)
1. Recombinant tissue-plasminogen activator-induced thrombolysis after cerebral thromboembolism in mice. Kilic E; Hermann DM; Hossmann KA Acta Neuropathol; 2000 Mar; 99(3):219-22. PubMed ID: 10663962 [TBL] [Abstract][Full Text] [Related]
2. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906 [TBL] [Abstract][Full Text] [Related]
3. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506 [TBL] [Abstract][Full Text] [Related]
4. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Niessen F; Hilger T; Hoehn M; Hossmann KA Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350 [TBL] [Abstract][Full Text] [Related]
5. Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice. Hara T; Mies G; Hossmann KA J Cereb Blood Flow Metab; 2000 Oct; 20(10):1483-91. PubMed ID: 11043911 [TBL] [Abstract][Full Text] [Related]
6. A reproducible model of thromboembolic stroke in mice. Kilic E; Hermann DM; Hossmann KA Neuroreport; 1998 Sep; 9(13):2967-70. PubMed ID: 9804299 [TBL] [Abstract][Full Text] [Related]
7. The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke. Bednar MM; Quilley J; Russell SR; Fuller SP; Booth C; Howard D; Gross CE Neurosurgery; 1996 Aug; 39(2):352-9. PubMed ID: 8832673 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Overgaard K; Sereghy T; Pedersen H; Boysen G Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment. Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663 [TBL] [Abstract][Full Text] [Related]
10. A new rat model of thrombotic focal cerebral ischemia. Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491 [TBL] [Abstract][Full Text] [Related]
11. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?]. Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413 [TBL] [Abstract][Full Text] [Related]
12. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. Kilic E; Kilic U; Yulug B; Hermann DM; Reiter RJ J Pineal Res; 2004 Apr; 36(3):171-6. PubMed ID: 15009507 [TBL] [Abstract][Full Text] [Related]
13. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion. Miyazaki T; Kimura Y; Ohata H; Hashimoto T; Shibata K; Hasumi K; Honda K Stroke; 2011 Apr; 42(4):1097-104. PubMed ID: 21350203 [TBL] [Abstract][Full Text] [Related]
14. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice. El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study. Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993 [TBL] [Abstract][Full Text] [Related]
16. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window. Maeda M; Furuichi Y; Ueyama N; Moriguchi A; Satoh N; Matsuoka N; Goto T; Yanagihara T J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659 [TBL] [Abstract][Full Text] [Related]
17. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Gautier S; Petrault O; Gele P; Laprais M; Bastide M; Bauters A; Deplanque D; Jude B; Caron J; Bordet R Stroke; 2003 Dec; 34(12):2975-9. PubMed ID: 14615621 [TBL] [Abstract][Full Text] [Related]
18. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator. Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117 [TBL] [Abstract][Full Text] [Related]
19. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor. Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115 [TBL] [Abstract][Full Text] [Related]